Cancer thrives by hijacking the body’s own basic survival systems, making it hard to attack tumors without collateral damage and side effects. Now, researchers at Cornell’s Weill Institute for Cell and Molecular Biology have discovered what may be a less invasive strategy that shows promise as a potential therapeutic pathway.
Continue Reading this article here
